In a country where dengue claims hundreds of lives each year and strikes hardest in the margins, Brazil has gained a new tool against the disease — though access to it, for now, follows the familiar contours of inequality. Qdenga, a Japanese-made vaccine with broad efficacy across all four dengue strains, has arrived in private pharmacies at a price that places it beyond the reach of most Brazilians. The public health system weighs its options slowly, while the virus does not wait.
Valor Econômico
· Sep 27, 2023
· health
· 3 min de lectura
High
Verificación: Verificado
Qdenga, nova vacina tetravalente contra dengue, já está disponível na rede privada brasileira
Brazil recorded 920 dengue deaths through August 2023, with Southeast region accounting for 515 deaths, disproportionately affecting elderly and chronic disease patients.
◉
Health & Medicine
2834 artículos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% coincidencia
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% coincidencia
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% coincidencia
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% coincidencia
Berlin admits American Ebola patient as outbreak kills 131 in Congo
Folha de S.Paulo · 90% coincidencia
Cobertura Relacionada
Folha de S.Paulo · Aug 26
Ônibus escolar cai em ribanceira e deixa duas crianças feridas em SC
Ônibus escolar com dez crianças caiu dez metros em ribanceira em Santa Catarina. Duas crianças ficaram feridas e foram h…
G1 · Aug 26 Incêndio em hospital do Paquistão mata ao menos 15 bebêsPelo menos 15 recém-nascidos morreram em incêndio no hospital PIMS em Islamabad, causado por falha no sistema de ar-cond…
G1 · Aug 26 Zelador agredido com paulada evolui na UTI, mas segue internado no DFZelador agredido há 15 dias por homem em situação de rua apresenta melhora clínica na UTI, respondendo a estímulos e com…
Google News · Aug 26 Diretor do Atlético-MG acusa Kaio Jorge de 'maldade e deslealdade' após lance polêmicoDirigente do Atlético-MG acusa Kaio Jorge de jogada maldosa e desleal que resultou em queda do zagueiro Ruan Tressoldi, …
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Japan's Takeda Pharma introduces tetravalent dengue vaccine Qdenga in Brazil's private sector, marking significant pharmaceutical market expansion in Latin America with 80.2% efficacy.
Escalation Risk
low
Confidence
HIGH
Brazil
Latin America
Japan
Southeast Asia
Japanese pharmaceutical dominance in tropical disease vaccines strengthens; Takeda gains market share in high-burden dengue regions; Brazil's healthcare inequality deepens as private access precedes public availability; potential geopolitical advantage for Japan in health diplomacy within BRICS and developing nations.
Similar to polio vaccine rollout patterns where private sector adoption preceded universal public health integration, creating temporary healthcare access disparities in developing economies.
Lente Económico
📈
Takeda's Qdenga dengue vaccine launches in Brazil's private healthcare at R$364-390/dose with 80.2% efficacy, expanding treatment options while SUS inclusion remains under evaluation.
Market Signal
bullish
Confidence
HIGH
Pharmaceutical/Biotechnology
Private Healthcare
Retail Pharmacy
Public Health Systems
Medical Tourism
Private healthcare consumers gain access to advanced dengue protection but face out-of-pocket costs (R$728-780 for full course). Lower-income populations dependent on SUS remain without access, potentially increasing healthcare inequality. Demand for private vaccination services expected to rise.
Ministry of Health must evaluate SUS incorporation, requiring budget allocation and cost-benefit analysis. Potential for negotiated pricing with Takeda to improve public accessibility. May influence future vaccine procurement strategies and public-private healthcare partnerships.